Clinical Trial Detail

NCT ID NCT01776307
Title A Study of BBI608 in Adult Patients With Advanced Colorectal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors Boston Biomedical, Inc

colorectal cancer


Cetuximab + Napabucasin

Capecitabine + Napabucasin

Napabucasin + Panitumumab

Age Groups: adult senior

Additional content available in CKB BOOST